{"meta":{"query_hash":"638044ed6f14","filters":{"venue":"Journal of Pharmaceutical Investigation"},"cohort_total":6,"direct_labels_cover":0,"predictions_cover":6,"exported":6,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/638044ed6f14","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+Pharmaceutical+Investigation"},"results":[{"id":"W2041109526","doi":"10.1007/s40005-014-0142-3","title":"A rapid and selective LC–MS/MS method for the quantification of aripiprazole in beagle dog plasma and its application to a pharmacokinetic study","year":2014,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Investigation","topic":"Analytical Methods in Pharmaceuticals","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Optech (Canada)","funders":"","keywords":"Aripiprazole; Chromatography; Chemistry; Beagle; Pharmacokinetics; Selected reaction monitoring; Electrospray ionization; Analyte; Mass spectrometry; Tandem mass spectrometry; Pharmacology; Medicine","score_opus":0.09729894129431453,"score_gpt":0.4388420423838734,"score_spread":0.3415431010895589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041109526","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6564337,0.023899822,0.30328307,0.0018467698,0.00092156604,0.0016422081,0.003012079,0.004309811,0.004650871],"genre_scores_gemma":[0.76244664,0.008840756,0.21611625,0.002024564,0.00033783788,0.0011036459,0.0014588314,0.00023576204,0.0074357125],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988148,0.00023924788,0.00008068908,0.0003467065,0.00044675337,0.00007183195],"domain_scores_gemma":[0.99938846,0.00012262558,0.00014198998,0.00004730379,0.0001987428,0.00010080991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016287364,0.0009308569,0.0008745901,0.00093971647,0.00070569804,0.00055058696,0.0007525062,0.0014889586,0.0011447034],"category_scores_gemma":[0.00167174,0.00082028256,0.0005173028,0.00041563658,0.0008083478,0.0008623473,0.0004776471,0.0013882925,0.0009123477],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078833324,0.00011553639,0.0008829069,0.00016800013,0.000089063855,0.00015888891,0.000051575218,0.00020769378,0.97274256,0.00016560765,0.00059280737,0.024037074],"study_design_scores_gemma":[0.00040041044,0.0047176844,0.0103129875,0.000043335192,0.00037480317,0.0070147337,0.000079337275,0.009955894,0.9528941,0.0002494006,0.013785267,0.00017207091],"about_ca_topic_score_codex":0.0018531978,"about_ca_topic_score_gemma":0.004266524,"teacher_disagreement_score":0.0018531978,"about_ca_system_score_codex":0.00062809256,"about_ca_system_score_gemma":0.0017040872,"threshold_uncertainty_score":0.008613706},"labels":[],"label_agreement":null},{"id":"W2605780223","doi":"10.1007/s40005-017-0327-7","title":"Evaluation of a microemulsion-based gel formulation for topical drug delivery of diclofenac sodium","year":2017,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Investigation","topic":"Advancements in Transdermal Drug Delivery","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":80,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Taibah University; University of Alberta","keywords":"Diclofenac Sodium; Microemulsion; Chemistry; Chromatography; Solubility; Zeta potential; Diclofenac; Drug delivery; Viscosity; Penetration (warfare); Pulmonary surfactant; Materials science; Organic chemistry; Nanotechnology; Nanoparticle; Biochemistry","score_opus":0.2725304800403541,"score_gpt":0.4987172540220918,"score_spread":0.22618677398173775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2605780223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993936,0.002426481,0.0026517583,0.00008776439,0.000048932165,0.00009933625,0.00007032242,0.00002615032,0.0006532246],"genre_scores_gemma":[0.9898949,0.0022381172,0.0060732886,0.000045263663,0.0000140126585,0.000047339385,0.000095069234,0.000014318376,0.0015777418],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989736,0.00001734028,0.000008992005,0.00001915532,0.00003973449,0.000017529681],"domain_scores_gemma":[0.9998882,0.000022979071,0.000026428252,0.000004046697,0.000038764632,0.000019577983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024961992,0.00021572778,0.00019565063,0.00019427946,0.00015475556,0.00017236239,0.00016575833,0.0002511008,0.0006223735],"category_scores_gemma":[0.00024119738,0.000115112365,0.0002628962,0.00009284354,0.00015003629,0.00026150228,0.00012434067,0.000275016,0.00011767545],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020960053,0.000099212535,0.00007695772,0.00013800764,0.000008270025,0.000044729426,0.000023204257,0.000066097804,0.99566674,0.000029829544,0.000027633741,0.0036096247],"study_design_scores_gemma":[0.000048334143,0.0032566749,0.0010092908,0.000011008712,0.000056493678,0.00010324054,0.00003517141,0.00080962945,0.993425,0.000007969792,0.0012293792,0.000007786361],"about_ca_topic_score_codex":0.0008962422,"about_ca_topic_score_gemma":0.0015954063,"teacher_disagreement_score":0.0008962422,"about_ca_system_score_codex":0.00016521315,"about_ca_system_score_gemma":0.0002789757,"threshold_uncertainty_score":0.0020819902},"labels":[],"label_agreement":null},{"id":"W2895673871","doi":"10.1007/s40005-018-0408-2","title":"Orally disintegrating dosage forms","year":2018,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Investigation","topic":"Drug Solubulity and Delivery Systems","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Dosage form; Active ingredient; Immediate release; Pharmacology; Patient compliance; Drug; Chemistry; Medicine","score_opus":0.21208761167724247,"score_gpt":0.4768319720973726,"score_spread":0.26474436042013016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2895673871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6959093,0.098801,0.06492494,0.0018751108,0.0016339602,0.0021018374,0.0025125805,0.0021558695,0.13008535],"genre_scores_gemma":[0.71018434,0.051121395,0.040920287,0.00093380036,0.000542047,0.00058176176,0.0015698748,0.00017303662,0.19397347],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998485,0.000018830753,0.00001216568,0.000026236627,0.00007818108,0.000016071048],"domain_scores_gemma":[0.9999275,0.000015313733,0.00002277552,0.0000067267774,0.000016244769,0.000011406875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018890909,0.00047722293,0.0003147769,0.0003985739,0.00017066272,0.00031171733,0.00024591846,0.0002963137,0.00794092],"category_scores_gemma":[0.00019955591,0.00014224781,0.00018189424,0.00023954292,0.00015481487,0.00031883252,0.00019152532,0.0006206027,0.0030278394],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005373335,0.00029847035,0.00030807639,0.00068654533,0.000025070069,0.00028098014,0.00009901769,0.0000802471,0.70491165,0.0012546361,0.0034774994,0.28804046],"study_design_scores_gemma":[0.00022958565,0.0055003604,0.0048804586,0.000115508214,0.00014738683,0.0019631807,0.0000854881,0.0004972707,0.79575706,0.00027992963,0.1905202,0.000023613467],"about_ca_topic_score_codex":0.00018249759,"about_ca_topic_score_gemma":0.0003764094,"teacher_disagreement_score":0.00794092,"about_ca_system_score_codex":0.00009444352,"about_ca_system_score_gemma":0.00020831524,"threshold_uncertainty_score":0.026565015},"labels":[],"label_agreement":null},{"id":"W4289516766","doi":"10.1007/s40005-022-00582-y","title":"Development of a patient-centric formulation of tegoprazan, a novel potassium-competitive acid blocker, using modified-release drug-coated pellets","year":2022,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Investigation","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novelis (Canada)","funders":"Ministry of Science and ICT, South Korea","keywords":"Pellets; Capsule; Enteric coating; Coating; Materials science; Dissolution; Particle size; Dissolution testing; Chemistry; Chemical engineering; Nuclear chemistry; Chromatography; Polymer; Ethyl cellulose; Nanotechnology; Composite material; Organic chemistry","score_opus":0.061149302163599706,"score_gpt":0.32588396098121775,"score_spread":0.26473465881761804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289516766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89941037,0.010240474,0.083466485,0.00056705164,0.00060825195,0.0010177924,0.0005512031,0.00057596655,0.0035624695],"genre_scores_gemma":[0.91550845,0.0051002144,0.073750176,0.00023321093,0.00012843855,0.00030699672,0.0005172456,0.00011455657,0.0043406924],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997764,0.00003568036,0.000025602336,0.000040663002,0.00010012743,0.000021486216],"domain_scores_gemma":[0.99985516,0.000023649192,0.000053538643,0.000011184285,0.000031359352,0.000025155163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033491402,0.00042522678,0.00041165814,0.00022453279,0.00011287421,0.0004169052,0.0005770073,0.00050822046,0.0007810404],"category_scores_gemma":[0.00047460923,0.000286528,0.00037517096,0.00011099472,0.00015636119,0.0003357412,0.0002342249,0.0006945285,0.00047163788],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008927816,0.00024286288,0.00034737575,0.0003263203,0.00006752733,0.00030603513,0.00004978208,0.00038357743,0.95017815,0.00028783467,0.0003291732,0.046588574],"study_design_scores_gemma":[0.00062993745,0.007702472,0.003923266,0.00005015782,0.00030233007,0.0020973382,0.000049841306,0.004424336,0.96078247,0.000055968387,0.019922331,0.00005956355],"about_ca_topic_score_codex":0.00028936632,"about_ca_topic_score_gemma":0.00040341885,"teacher_disagreement_score":0.0007810404,"about_ca_system_score_codex":0.000109605746,"about_ca_system_score_gemma":0.00024533673,"threshold_uncertainty_score":0.0026128292},"labels":[],"label_agreement":null},{"id":"W4406783172","doi":"10.1007/s40005-024-00718-2","title":"Thioester platform to develop potential nanomedicines for breast cancer therapy","year":2025,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Investigation","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research","keywords":"Breast cancer; Cancer therapy; Thioester; Medicine; Cancer; Computational biology; Internal medicine; Chemistry; Biology; Biochemistry","score_opus":0.04277358785032104,"score_gpt":0.3668777419741542,"score_spread":0.32410415412383314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406783172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7610622,0.017770315,0.17806706,0.0014891097,0.0007419992,0.00063900976,0.00082106213,0.0011691339,0.03824017],"genre_scores_gemma":[0.9404961,0.005270972,0.032959808,0.0005099355,0.00006828713,0.00030585352,0.00039724805,0.000066553584,0.019925263],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999064,0.000020862215,0.000006479685,0.000021578302,0.000023549079,0.000021143269],"domain_scores_gemma":[0.99992144,0.000015542917,0.000024093273,0.0000085144275,0.000019407627,0.000010942567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030923478,0.00045869753,0.00022342894,0.00019784698,0.00015279849,0.00028534487,0.00037562117,0.00063055585,0.0030061202],"category_scores_gemma":[0.00023686369,0.00018515089,0.00027536156,0.00013992838,0.00014815188,0.0005197966,0.00035013186,0.0006281431,0.0010088701],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012343317,0.00006556905,0.000067925575,0.00019561418,0.000014849338,0.00018472715,0.000032009786,0.0006255163,0.9841899,0.001850478,0.00040986834,0.012240062],"study_design_scores_gemma":[0.000024013514,0.0006867722,0.00017874857,0.000016677976,0.00002292778,0.0002053745,0.00002118492,0.0020154791,0.9840098,0.00037560932,0.012430142,0.000013312881],"about_ca_topic_score_codex":0.00020325907,"about_ca_topic_score_gemma":0.00035357205,"teacher_disagreement_score":0.0030061202,"about_ca_system_score_codex":0.000190987,"about_ca_system_score_gemma":0.00023950891,"threshold_uncertainty_score":0.010056496},"labels":[],"label_agreement":null},{"id":"W766751705","doi":"","title":"Conducts and Analysis of Bioavailability & Bioequivalence Studies in Canada -Part A: Oral Dosage Formulations Used for Systemic Effects-","year":2000,"lang":"en","type":"article","venue":"Journal of Pharmaceutical Investigation","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bioequivalence; Bioavailability; Pharmacology; Dosage form; Medicine","score_opus":0.57195039080542,"score_gpt":0.5044450307002595,"score_spread":0.0675053601051605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W766751705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8880486,0.011811779,0.04146728,0.0025376664,0.00010553875,0.008449044,0.01725448,0.00034467215,0.029981056],"genre_scores_gemma":[0.95179725,0.0020176242,0.03459684,0.0003832027,0.000019672487,0.00061846053,0.0034485173,0.000068315,0.007050278],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9782178,0.01052806,0.0015647899,0.0013353466,0.007351063,0.0010029034],"domain_scores_gemma":[0.9600338,0.016427513,0.0056932317,0.001876657,0.014989565,0.0009793253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02536735,0.0004287689,0.0009716761,0.0021370496,0.0017272877,0.001517773,0.001224928,0.00060637266,0.0023149147],"category_scores_gemma":[0.05915271,0.00058742735,0.0013804651,0.0034074346,0.0009294217,0.00054588146,0.00077494007,0.0008179761,0.00031194446],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011644875,0.0012066724,0.5223562,0.0034991293,0.0032704645,0.00034599088,0.002844045,0.020128628,0.006102357,0.016817547,0.015027869,0.39675617],"study_design_scores_gemma":[0.0011938281,0.0030107354,0.91805136,0.00046446148,0.0020679773,0.00029434255,0.0013888526,0.030142225,0.010876141,0.0021270113,0.030239725,0.00014322501],"about_ca_topic_score_codex":0.9393069,"about_ca_topic_score_gemma":0.95370877,"teacher_disagreement_score":0.060693085,"about_ca_system_score_codex":0.03968733,"about_ca_system_score_gemma":0.108184814,"threshold_uncertainty_score":0.28795314},"labels":[],"label_agreement":null}]}